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A B S T R A C T
Background: In the Netherlands the incidence of tuber-
culosis (TB) has increased during the last decade. Growing
immigration and international travel were important
determining factors. To determine if this has resulted in
altered clinical manifestations of the disease, we assessed
the clinical spectrum of all TB cases diagnosed at our
hospital in the period 1994 to 2000.
Methods: All culture-proven TB cases during the study
period were retrospectively reviewed for clinical and
demographic data.
Results: Sixty-five patients were identified. Solitary pulmonary
TB was diagnosed in 33.9%, extrapulmonary TB in 51.8%
and combined pulmonary and extrapulmonary TB in 14.3%
of all cases. Patients were of foreign descent in 78.6% of
all cases. Incidence peaked between 15 to 45 years.
Decreased immunity was an important determining factor
in the older patients. Presenting symptoms were mostly
aspecific causing an important doctor’s delay in establishing
the diagnosis in 25%. Mortality was 3.6% and isoniazid
resistance 3.6%
Conclusions: Our data suggest an increase in the percentage
of extrapulmonary TB concomitantly with an increasing
percentage of patients of foreign descent. Because of
aspecific presenting symptoms, TB was often diagnosed
late. Treatment is mainly hindered by non-compliance
and a high index of suspicion is necessary in making the
diagnosis. 
I N T R O D U C T I O N
Tuberculosis (TB) remains one of the largest global health
problems of our time. It accounts for approximately three
million deaths each year and 1.7 billion people, one third
of the world’s population, are infected with Mycobacterium
tuberculosis. This reservoir of infected persons results in
eight million new cases of TB each year.1-3 The spread of
HIV/AIDS, the breakdown in health services and the
emergence of multidrug-resistant M. tuberculosis are
contributing to the impact of the disease.2-6 The growing
epidemic led the World Health Organisation to declare
TB a global emergency in 1993.
In the Netherlands the incidence of TB decreased during
the course of the 20th century. However, in the last decade
an important increase occurred, with numbers rising
from 1227 TB cases in 1987 to 1535 cases in 1999.7,8
Immigration and international travel seem to be the most
important determining factors.3,7,9,10 Besides alterations in
incidence and demographic characteristics, the presentation
of TB has changed. In the US the proportion of extra-
pulmonary TB remained fairly constant in the period 1977
to 1981. However, during subsequent years, as the incidence
of pulmonary TB declined at a faster rate than that of
extrapulmonary TB, the proportion of extrapulmonary
TB gradually rose, with its incidence rising from 14.4%
of all TB cases in 1977 to 17.5% in 1986.11-13 In the
Netherlands extrapulmonary TB accounted for 576 (31%)
of all TB cases in 1999, compared with 383 cases (24%)
in 1993. When nationality is taken into account, the
incidence of extrapulmonary TB is much higher among
patients of foreign descent than among natives of the
Netherlands.7
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O R I G I N A L  A R T I C L E
In Rotterdam, and in other large cities, the incidence of TB
is much higher than in rural areas. The higher incidence
of TB and the growing number of newly diagnosed patients
can be explained by the increasing number of people
belonging to risk groups, such as immigrants and the
socially marginalised.7,14 To test the hypothesis whether the
clinical presentation of TB has changed in recent years
due to its altered epidemiology, we retrospectively reviewed
all cases of bacteriologically confirmed TB and compared
our data with published series from the literature.
P A T I E N T S  A N D  M E T H O D S
Rijnmond-Zuid Medical Centre, location Clara, is a 553-bed
hospital and serves a community of 147,197 persons,
accounting for 205,316 outpatient contacts each year. Patients
come from Rotterdam (592,673 inhabitants), as well as
from the surrounding areas. It is the largest haemodialysis
centre in the area and approximately 40 residents are being
trained. The hospital is not a centre for HIV/AIDS. These
patients are referred to the nearby university hospital.
By screening the database of the microbiology laboratory
of our hospital, we identified all patients who had one or
more positive culture results for Mycobacterium species and
were treated between 1 January 1994 and 31 August 2000.
TB cases which were not bacteriologically confirmed were
not included. We reviewed the records of all thus identified
patients for demographic and clinical data, such as age,
gender, country of birth, presenting symptoms, localisation
of TB and comorbidity. Treatment and follow-up were
studied, as well as Mycobacterium species and resistance
to antituberculosis drugs. Pulmonary TB was defined as a
positive culture from sputum or bronchoalveolar lavage
(BAL) fluid. Pleural and mediastinal TB were considered
as extrapulmonary localisations of TB.
During the study period two solid culture media were
used, the agar-based Middlebrook 7H11 and the egg-based
Löwenstein-Jensen media. Histological material was
evaluated with both a fluorochrome stain with phenolic
auramine and a Ziehl-Neelsen stain. Other specimens
were evaluated with Ziehl-Neelsen staining only. 
R E S U L T S
Bacteriological studies
Between January 1994 and August 2000 a total of 63 patients
with a positive culture for Mycobacterium species were
identified. Seven cultures were atypical Mycobacteria. These
patients were not included in the study. Of the seven cases
of atypical mycobacterial infections, one patient was a
two-year-old girl, who developed an abscess on her shoulder
after local BCG vaccination. Culture demonstrated an
M. bovis BCG. After surgical incision and drainage the
patient recovered and no further treatment was necessary.
Three patients had a positive culture for M. avium. All three
patients had either chronic obstructive pulmonary disease
(COPD) with chronic corticosteroid use or an underlying
malignancy. M. avium caused no serious pulmonary illness
and the patients received no antimycobacterial treatment.
Two of the other patients had an infection with M. malmoense
and one had M. kansasii. Mycobacterial infection caused
pulmonary illness in these three patients and all were treated
with tuberculostatic drugs. Again, a malignancy or COPD
with chronic corticosteroid use were present in these patients.
In 56 patients a Mycobacterium from the M. tuberculosis
complex was identified. Two patients had an infection with
M. bovis. A patient from Morocco presented with a painless
swelling of a cervical lymph node. The lymph node was
excised and histological examination showed a caseating
granuloma. Biopsy culture and Mantoux testing were
positive. The other patient was a native from the Netherlands
and presented with slowly progressive shortness of breath,
weight loss and non-productive cough. She had been treated
for TB some fifty years before. Chest X-ray demonstrated
unilateral pleural effusion. Pleural biopsy showed granulo-
matous, caseating inflammation. M. bovis was isolated from
pleural fluid. Culture was positive for M. tuberculosis in 54
patients. Seven patients carried a strain of M. tuberculosis
which was resistant to one antituberculosis drug: two to
isoniazid (INH), one to rifampicin, three to streptomycin
and one to pyrazinamide. No multidrug resistance was
observed. Of the seven subjects with drug resistance, six
were of foreign descent. None of these patients had a history
of previous TB treatment. 
A total of 66 positive cultures were obtained. Nine patients
had a positive culture from two or more localisations.
M. tuberculosis was most frequently cultured from lymph
nodes (25.8%), sputum (22.7%) and BAL fluid (18.2%).
The remaining positive cultures were obtained from an
abscess (12.1%), pleural fluid (7.6%) or another source in
13.6%. Of the 15 sputum culture-positive patients, seven
were smear-positive (Ziehl-Neelsen method) and five were
smear-negative. Of the 12 positive BAL cultures, microscopic
examination was positive in four patients and negative in
six. Information on microscopic examination could not be
retrieved in five patients. 
Demographics
Twenty-seven patients were male with a mean age of 40.2
years (range 18 to 75 years) and the 29 females had a
mean age of 40.7 years (range 13 to 83 years). Of all
56 patients, 21.4% were natives of the Netherlands and
78.6% of foreign descent. Patients from Turkey, Morocco
and Surinam, the three largest ethnic groups in the
Netherlands, accounted for 5.4, 10.7 and 12.5% of all
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cases, respectively. Of the remaining patients 21.4% were
of African (other than Morocco) and 25% of Asian
descent. Two patients were of European origin.
Clinical manifestations
As illustrated in table 1, presenting symptoms were often
aspecific (cough, fever and wasting). Of all patients, solitary
pulmonary TB accounted for 19 cases (33.9%). A total of
29 patients were diagnosed with extrapulmonary TB,
representing 51.8% of all cases. In eight patients (14.3%) 
a diagnosis of both pulmonary and extrapulmonary TB
was made. Localisation and frequency of extrapulmonary
TB are summarised in table 2.
Tuberculin status
Of the 56 patients, 12 underwent tuberculin testing (Mantoux
method). Nine patients were considered to have a positive
result (>10 mm induration) and three were negative. Of
these three patients one had pulmonary TB, one had
tuberculous peritonitis and one tuberculous pleuritis.
Immune suppression was present in one of the three
patients, who was suffering from multiple myeloma and
was treated with prednisone and melphalan. He had a
history of pulmonary TB some 50 years before.
History of previous TB
Six patients had in the past been treated for TB. In two
patients (aged 36 and 72 years) TB had been diagnosed in
another hospital several years before. Due to non-compliance
both had been treated inadequately. Four patients (two aged
67, one 75 and one 80 years) were treated for TB in a
sanatorium some 30 to 50 years earlier. One of them
received prednisone and melphalan shortly before reacti-
vation of TB occurred. All four patients were natives of
the Netherlands.
Associated medical problems/underlying diseases
Of all patients, 39 had no underlying disease or any other
medical problems. Six patients had diabetes mellitus,
three patients had a malignancy and four patients were
receiving cytostatic or immunosupressive treatment. Five
patients were on chronic intermittent haemodialysis. Five
patients had other associated medical problems such as
drug or alcohol abuse. No patients were found to be positive
for HIV or suspected of having HIV/AIDS. It should be
noted that routine HIV screening was started after 1996.
Delay in diagnosis
In 60.7% of all cases a diagnosis of TB was made within
four weeks following admission. In 14.3% the diagnosis
was established between four and eight weeks. In 17.9%
(ten cases) it took between eight weeks and six months
before a definitive diagnosis of TB was made. Of these ten
patients, two had pulmonary TB, six had extrapulmonary
TB and two had both types of TB. In 3.6% (two cases) it
took between six months and a year before a diagnosis of
TB was made. Both had extrapulmonary TB. It took more
than a year to establish the diagnosis in two patients. One
patient had extrapulmonary TB and one pulmonary TB. 
Treatment
Fifty-five patients (98.2%) received INH and 54 (96.4%)
rifampicin. Thirty-eight patients (67.9%) were treated with
ethambutol and 48 (85.7%) with pyrazinamide. None of the
patients were treated with streptomycin. Sixteen patients
(28.6%) received antituberculous treatment for a duration
of six to nine months and 26 patients (46.4%) were treated
for nine to 12 months. One patient was treated for more than
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Table 1
Presenting symptoms in 56 patients with tuberculosis
SYMPTOM NUMBER PERCENT
Cough 28 50.0%
Fever 23 41.1%
Wasting 23 41.1%
Lymph node swelling 15 26.8%
Malaise 11 19.6%
Dyspnoea 9 16.1%
Haemoptysis 6 10.7%
Abscess 5 8.9%
Abdominal complaints 5 8.9%
Bone pain 5 8.9%
Night sweating 5 8.9%
Chest pain 3 5.4%
Other 6 10.7%
Table 2
Localisation and frequency of tuberculosis in 56 patients*
ORGAN SYSTEM NUMBER PERCENT
Pulmonary 19 33.9%
Pleural 7 12.5%
Lymphatic 18§ 32.1%
Cervical 14 25.0%
Mediastinal 5 8.9%
Intra-abdominal 4‡ 7.1%
Colon 1 1.8%
Small bowel 1 1.8%
Peritoneum 3 5.4%
Skeletal 6 10.7%
Vertebral column 4 7.1%
Clavicle 1 1.8%
Knee 1 1.8%
Skin/abscess 5 8.9%
Cerebrum 1 1.8%
Total 62
* Six patients had two EP localisations of TB, § one patient had both cervical and
mediastinal lymphatic TB, ‡ one patient had both small intestinal and colonic TB.
one year. Five patients had not completed the full course
of treatment by the time of writing. Of six patients exact
information on the duration of treatment could not be
retrieved. Four patients suffered from polyneuropathy,
five had liver enzyme abnormalities and five patients had
other complications. Two patients died. One patient had
multiple myeloma with renal insufficiency complicated by
pneumonia. Culture from BAL fluid revealed M. tuberculosis
post mortem. The second patient was on chronic intermittent
haemodialysis and developed a tuberculous chest abscess.
On top of uraemic and diabetic polyneuropathy he developed
a severe polyneuropathy due to tuberculostatic drugs leading
to respiratory insufficiency. After five months of mechanical
ventilation the patient died of sepsis. 
Follow-up
Of all patients, 31 (55.5%) completed their full course of
antituberculosis treatment without any complications.
Non-compliance occurred in 11 (19.6%) patients, leading to
complete loss to follow-up in six patients and prolongation
of treatment in five.
D I S C U S S I O N
The increased TB incidence in the Netherlands during
the last decade was mainly caused by immigration from
countries of high TB prevalence.7,8 The aim of our study
was to assess the clinical spectrum of TB and to determine
whether these epidemiological and demographic changes
have led to a different clinical presentation of the disease.
We found 78.6% of all patients with culture-proven TB to
be of foreign descent, which is a high percentage compared
with the national data. In 1998, patients of foreign descent
accounted for 60% of all TB cases in the Netherlands.7
In a recent study conducted at Amsterdam’s university
hospital, patients of foreign descent were found to account
for 70% of all TB cases.10 In comparison, Smelt et al. found
25% of TB patients to be of foreign descent in their study
conducted in the early eighties.15 The national data of 1985
showed 30% of all TB cases to be of foreign descent.7 Our
results reflect the demographics of the Rotterdam area, where
people of foreign descent made up approximately 40% of
the total population in 2000 (source: www.cbs.nl) and are
consistent with the view that TB is becoming increasingly
concentrated in urban areas.16-18
The age distribution showed a peak in (young) adults and
in the elder population. Patients in the younger age group
were most often of foreign descent and had primary
infections without associated medical problems. Elderly
patients were mostly born in the Netherlands. Reactivation
of TB accounted for 80% of all TB cases in Dutch patients
of over 60 years of age. Decreased immunity, due to
underlying diseases or immunosupressive treatment, was
an important determining factor in this age group and is
consistent with the view that the elderly are a population
at risk for TB.19,20
Presenting symptoms were mostly aspecific as described
by other authors.12,16,18 This can be attributed in part to 
the remarkably high number of solitary extrapulmonary
TB (51.8%) in our population. Another 14.3% of all patients
had extrapulmonary combined with pulmonary TB. In the
Netherlands, the incidence of extrapulmonary TB was 36%
in 1998 with combined pulmonary and extrapulmonary
TB accounting for 8% of all cases.7 Extrapulmonary TB is
more frequent among patients of foreign descent (40%)
than among natives of the Netherlands (30%).7 Table 3
summarises the results of 20 studies from various parts
of the world.10-13,15,17-19,21-32 On average the percentage of
extrapulmonary TB varies between 20 and 40%. The
higher percentage we observed could be explained by the
large number of patients of foreign descent and the fact
that in the Netherlands immigrants routinely undergo
screening for pulmonary TB by means of chest radio-
graphy. Extrapulmonary TB will not often be diagnosed in
this way.
An important doctor’s delay in diagnosis occurred in 25%
of the patients. We found three main reasons for this delay.
Sometimes inconclusive histology or negative culture results
together with aspecific presenting symptoms led the clinician
to consider diseases other than TB, such as sarcoidosis,
Brucellosis or cat-scratch disease. After failure to respond
to the instituted therapy, and repeated biopsies and 
cultures, TB was diagnosed. A second group of patients
experienced delay because of concomitant diseases masking
TB. Respiratory tract infections caused by pathogens other
than Mycobacteria were most often implicated. Treatment
failure or recurrence of symptoms led to reconsideration
of the differential diagnosis and a more thorough search for
TB. Finally, a low index of suspicion by general practitioners
or other medical specialists caused late referral to the
departments of pulmonology or internal medicine. Weir et al.
observed a similar range in delay in diagnosis, which varied
from days to years, with a median of two months.13 A lack
of experience with TB on the part of physicians due to its
decreasing incidence in the postsanatorium era has been
implicated.24 The elderly and patients not belonging to
traditionally high-risk populations appear to be at greatest
risk of having unsuspected disease.19
Sputum culture was positive in 55.6% of cases of pulmonary
TB and culture from BAL fluid in the remaining 44.4%.
Approximately 40% of patients with pulmonary TB
were found to be smear positive on direct microscopic
examination. Reviews on sputum analysis in the diagnosis
of TB have found the incidence of smear positivity ranging
from 32 to 55.3% and culture positivity from 70 to 96% of
patients.18,33
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The percentage of INH-resistant Mycobacteria was low (3.6%)
and comparable with the national number of 6 to 7%.7
All strains of single-drug resistant Mycobacteria, except for
one, were isolated from immigrants from areas of high
TB prevalence. None of these patients had been treated for
TB in the past. Non-compliance was an important problem
and all cases occurred in patients of foreign descent. Side
effects of antituberculosis drugs caused non-compliance
in two patients. In addition, one patient experienced
worsening of a psychiatric disorder, causing loss to follow-up.
Close cooperation with the public health service often led
to early detection of defaulting and to measures ensuring
completion of treatment, such as directly observed therapy
(DOTS). Recently, Borgdorff et al. found an overall risk of
defaulting from TB treatment of approximately 10% per
year.34 Recent and illegal immigrants showed higher rates
of defaulting. The high percentage of patients of foreign
descent may explain the relatively high percentage of
non-compliance in our study. Shortening the duration of
standard treatment from nine to six months, as was
recommended in 1996,8,35,36 more frequent application of
DOTS and improved coordination with the public health
service in the follow-up of high-risk patients, may further
improve treatment outcome in the future. 
C O N C L U S I O N S
Extrapulmonary tuberculosis was present in 51.8% of all cases,
which was high compared with earlier surveys showing
percentages ranging between 10 and 40%. This change in
the incidence of extrapulmonary TB occurred concomitantly
with an increase in the percentage of TB patients of foreign
descent (78.6% versus around 30% in the mid-80s). Mortality
of TB was 3.6%. Extrapulmonary TB was often diagnosed
late because of mostly aspecific presenting symptoms.
This resulted in a greater than expected doctor’s delay.
Treatment was mainly hindered by non-compliance. Drug
resistance was not a major problem during treatment.
Although TB remains a relatively rare disease, a high
index of suspicion is necessary in making the diagnosis. 
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